9:12 AM
Leo Group India
| ||
| ||
| Another U.S. Pharmaceutical Company Commences Unifill Stability Studies ... Daily Markets (press release) Mr. Alan Shortall, CEO of Unilife, said: "The supply of Unifill syringes to this pharmaceutical customer for use with so many of their injectable drugs at one time is a major accomplishment. The customer cited the unique value proposition of the ... See all stories on this topic » | ||
| Teva Pharmaceutical Industries Ltd reports launch of USD3.0bn syndicated ... MENAFN.COM According to the company's EVP and CFO, Eyal Desheh, by signing this new revolving credit facility, with its increased size and extended term, the company took another step towards its new strategy and secured ample liquidity to support its future growth. See all stories on this topic » | ||
| ONO PHARMACEUTICAL CO., LTD. : Phase III Trial of L-BLP25 (Stimuvax®) in ... 4-traders Merck Serono, a division of Merck, Darmstadt, Germany, announced today that the Phase III START trial of its investigational product L-BLP25 (formerly referred to as Stimuvax®, a MUC1 antigen-specific cancer immunotherapy) in patients with unresectable ... See all stories on this topic » | ||
| Stora Enso and Chalmers enter collaboration in intelligent pharmaceutical ... Packaging Europe Stora Enso and Chalmers' Encubator have reached a co-operation agreement under which Stora Enso will act as a partner to Encubator. The focus of the collaboration is an innovation project developing intelligent pharmaceutical packaging. The idea comes ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment